Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$437.42 - $470.64 $1.18 Million - $1.27 Million
-2,700 Reduced 75.0%
900 $416,000
Q3 2023

Nov 14, 2023

SELL
$402.4 - $446.42 $1.97 Million - $2.19 Million
-4,900 Reduced 57.65%
3,600 $1.57 Million
Q2 2023

Aug 14, 2023

BUY
$354.01 - $427.31 $2.16 Million - $2.61 Million
6,100 Added 254.17%
8,500 $3.63 Million
Q1 2023

May 15, 2023

BUY
$335.35 - $386.06 $570,095 - $656,302
1,700 Added 242.86%
2,400 $854,000
Q4 2022

Feb 14, 2023

BUY
$346.68 - $397.58 $242,676 - $278,306
700 New
700 $0

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $90B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.